Head-to-head · WeighScore
Pallas Health vs Synergy Rx
By GLP-1 ScorecardUpdated
Score comparison
Synergy Rx has the higher recorded score — 76.2/100 to 69.3/100.
Synergy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Synergy Rx advertises online weight-loss care and a $100 welcome credit. Ask for the prescription price before relying on the credit.
Before you choose
Synergy Rx does not publish a semaglutide price, so its Synergy Rx review sets out what it does disclose, while the Pallas Health review explains the conditions attached to Pallas Health's figure. The semaglutide cost page compares published rates across the field. Ask Synergy Rx for a written total before treating either one as the cheaper choice.
If neither one fits, BiltRx vs Pallas Health and PauseRX vs Synergy Rx compare each of them with another graded program, and the list of alternatives to Pallas Health ranks the programs closest to Pallas Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Pallas Health | Synergy Rx |
|---|---|---|
| WeighScore | 69.3/100 | 76.2/100 |
| Grade | C | C |
| Site position | #142 | #54 |
| Semaglutide | $139 first period, then $199 every four weeks (compounded; confirm selected quote) | Not disclosed |
| Tirzepatide | $179 first period, then $299 every four weeks (compounded; confirm selected quote) | Not disclosed |
| Coverage | Confirm treatment and visit requirements for your state | Not disclosed |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes first-period and four-week renewal amounts
- Explains when the charge is triggered and how to cancel future renewal
- Terms link to a pharmacy partner directory
What to consider
- Annual monthly equivalents do not establish the selected debit
- Once prescribed, the current cycle ordinarily is not prorated or refunded
- The six-month promise has separate eligibility and timing requirements
Strengths
- Publicly advertises a $100 welcome credit at checkout
- Describes an online assessment, consultation and delivery
What to consider
- No drug-specific price confirmed in the pages reviewed
- Terms say medical consultation fees are nonrefundable and prescription sales are final
- Confirm the assigned pharmacy, state eligibility and any renewal deadline
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.